Empowering India's Healthcare: Dr. Sujit Paul Unveils Davaindia's Commitment to Quality and Affordability
Dr. Paul highlighted that the generic sector of pharmaceutical companies currently holds a substantial portion of the Indian pharmaceutical market, exhibiting a growth rate approximately 500 basis points higher than its branded counterparts.
By Sunny Parayan![](images/ico-whatsapp.png)
![](images/ico-linkedin.png)
![](images/ico-twitter.png)
![](images/ico-facebook.png)
Redcliffe Labs Raises $42 Million in Series C Funding: A Step Toward Transforming Healthcare
In the coming years, Redcliffe Labs is expected to play a key role in transforming India’s healthcare landscape, bringing advanced diagnostics to millions of people and helping to build a healthier, more equitable society
By Sunny Parayan![](images/ico-whatsapp.png)
![](images/ico-linkedin.png)
![](images/ico-twitter.png)
![](images/ico-facebook.png)
Empowering India's Healthcare: Dr. Sujit Paul Unveils Davaindia's Commitment to Quality and Affordability
Dr. Paul highlighted that the generic sector of pharmaceutical companies currently holds a substantial portion of the Indian pharmaceutical market, exhibiting a growth rate approximately 500 basis points higher than its branded counterparts.
By Sunny Parayan![](images/ico-whatsapp.png)
![](images/ico-linkedin.png)
![](images/ico-twitter.png)
![](images/ico-facebook.png)
Redcliffe Labs Raises $42 Million in Series C Funding: A Step Toward Transforming Healthcare
In the coming years, Redcliffe Labs is expected to play a key role in transforming India’s healthcare landscape, bringing advanced diagnostics to millions of people and helping to build a healthier, more equitable society
By Sunny Parayan![](images/ico-whatsapp.png)
![](images/ico-linkedin.png)
![](images/ico-twitter.png)
![](images/ico-facebook.png)
![](images/prv-sm.png)
![](images/nxt-sm.png)